Group One Trading, L.P. Neuro Bo Pharmaceuticals, Inc. Transaction History

Group One Trading, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$1.22 - $2.5 $353 - $725	-290 Reduced 39.84%	438 $1,000
Q3 2021 Nov 12, 2021	SELL	$2.73 - $4.52 $3,210 - $5,315	-1,176 Reduced 61.76%	728 $3,000
Q2 2021 Aug 10, 2021	BUY	$2.74 - $4.63 $5,216 - $8,815	1,904 New	1,904 $6,000

Ticker NRBO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 888,693
Market Cap $2.4M
Description
NeuroBo Pharmaceuticals, Inc., a clinical-stage biotechnology company provides therapies for neurodegenerative, infectious, and cardiometabolic diseases. Its therapeutics programs include ANA001, an oral niclosamide formulation, which is in Phase 2/3 clinical trials to treat patients with moderate coronavirus disease (COVID-19); NB-01 for the tr...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.